Keywords: aronex, atragen, nda, insufficient, pharmaceuticals, been, informed

Aronex's Atragen NDA is "insufficient"

Article | 06 August 1999

Print This

Aronex Pharmaceuticals has been informed by the US Food and DrugAdministration that the invitation to discuss its New Drug Application ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in